Nicolab is excited to announce that it has achieved compliance with both the EU and UK Medical Device Regulations (MDR). This significant milestone confirms that our innovative StrokeViewer meets the highest safety and efficacy standards, empowering healthcare professionals with reliable tools for stroke diagnosis and management. With our EU and UKCA certificates, we are well-positioned to expand our reach and continue advancing healthcare solutions in the medical imaging field.

Nicolab is proud to participate in the UMBRELLA project, a groundbreaking initiative focused on improving stroke care in Europe. Through AI-driven solutions, Nicolab aims to enhance diagnosis, treatment, and patient outcomes, contributing to better stroke management across the continent.

Nicolab is excited to announce the integration of MR perfusion imaging into our platform, providing healthcare professionals with essential tools for stroke diagnosis and treatment. Our solutions adapt seamlessly to hospital workflows, enabling clinicians to access critical perfusion data and improve patient outcomes.

After presenting our abstract in partnership with Lahey Hospital at ESMINT, you can now read our publication in the Journal of Neurointerventional Surgery, exploring the potential of machine learning to accurately determine clot histological characteristics from baseline stroke imaging in the acute setting.

Nicolab, a distinguished pioneer in stroke workflow technology, is proud to announce that its CT Perfusion algorithm, which is integrated into the StrokeViewer® platform, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Michael Macilquham appointed Chief Executive Officer, brings bold vision and leadership to solve healthcare challenges with leading-edge technology.

Nicolab, a pioneering healthcare technology solutions provider, is pleased to announce the appointment of Frans van Belle to its esteemed Board of Directors.

We are excited to announce the integration of a new…

Gold Coast, Australia – Nicolab, a pioneering healthcare technology solutions…

Gold Coast, Australia – Nicolab, a renowned healthcare technology solutions…

Melbourne, Australia – Nicolab, a publicly unlisted Australian-based company, and…

Melbourne, Australia – Nicolab, a leading provider of healthcare technology…

Join our webinar on the 11th of May at 5 pm CET

MR CLEAN-LATE phase 3 trial shows positive results

One in six people will likely to have a stroke at some point in their life. Starting stroke treatment just a few minutes earlier can be the difference between life and death.

The European Innovation Council (EIC) confirms Nicolab’s vision for healthcare with a grant, choosing from more than 1,000 start-ups and small and medium-sized enterprises (SMEs) around Europe.

For International Women’s Day 2022 our CEO, Dr. Merel Boers, joins #IWDequals campaign to show the strength and diversity in the tech world.

StrokeViewer will support Laurentius Hospital in delivering faster life-saving treatments for patients.

Game changer: incredible app that will save Aussie lives.

Award given at #EICSummit 2021 in Brussels to recognize company founders making a true impact with their innovation.

Nicolab has an end-to-end artificial intelligence solution, StrokeViewer, that helps physicians to provide stroke patients with the right treatment, in time.

Inspiring entrepreneur and innovative researcher: Dr. Merel Boers is co-founder and CEO of Nicolab.

As the year draws to a close, we want to reflect on some highlights and milestones we have reached during an unusual and challenging year.

StrokeViewer opens a new chapter in stroke care for a network of 10 hospitals in The Netherlands.

StrokeViewer obtains CE mark.

Combining expertise of Amsterdam UMC and Nicolab to develop Stroke AI technologies using MR images.

Nicolab welcomes and emphasizes compliance with the GDPR.